MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

A

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

Search

Evolent Health Inc

Open

SectorGezondheidszorg

4.18 5.56

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.06

Max

4.25

Belangrijke statistieken

By Trading Economics

Inkomsten

30M

-21M

Verkoop

35M

480M

Winstmarge

-4.351

Werknemers

4,500

EBITDA

512K

15M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+142.17% upside

Dividenden

By Dow Jones

Volgende Winsten

19 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-321M

458M

Vorige openingsprijs

-1.38

Vorige sluitingsprijs

4.18

Nieuwssentiment

By Acuity

34%

66%

106 / 372 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

Evolent Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 jan 2026, 23:11 UTC

Winsten

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 jan 2026, 22:55 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 jan 2026, 21:39 UTC

Belangrijke Marktbewegers

Raytheon Down Following Trump Post Criticizing Company

7 jan 2026, 20:13 UTC

Belangrijke Marktbewegers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 jan 2026, 20:03 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 jan 2026, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

7 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 jan 2026, 23:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 jan 2026, 23:34 UTC

Marktinformatie

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 jan 2026, 23:29 UTC

Acquisities, Fusies, Overnames

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 jan 2026, 22:48 UTC

Marktinformatie

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 jan 2026, 22:46 UTC

Winsten

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 jan 2026, 22:45 UTC

Winsten

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 jan 2026, 22:43 UTC

Acquisities, Fusies, Overnames

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 jan 2026, 22:42 UTC

Winsten

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 jan 2026, 22:40 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 jan 2026, 22:31 UTC

Marktinformatie

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 jan 2026, 22:22 UTC

Marktinformatie

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 jan 2026, 22:01 UTC

Marktinformatie

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

7 jan 2026, 21:46 UTC

Marktinformatie

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 jan 2026, 21:22 UTC

Acquisities, Fusies, Overnames

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 jan 2026, 21:18 UTC

Acquisities, Fusies, Overnames

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 jan 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 jan 2026, 20:29 UTC

Acquisities, Fusies, Overnames

AbbVie Near Deal for Revolution Medicines -- Update

7 jan 2026, 20:27 UTC

Marktinformatie

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 jan 2026, 19:58 UTC

Marktinformatie

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 jan 2026, 19:48 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Peer Vergelijking

Prijswijziging

Evolent Health Inc Prognose

Koersdoel

By TipRanks

142.17% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 10.05 USD  142.17%

Hoogste 16 USD

Laagste 7 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Evolent Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Technische score

By Trading Central

10.33 / 10.95Steun & Weerstand

Korte Termijn

Very Strong Bullish Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

106 / 372 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat